Senti Biosciences Long Term Debt

Senti Biosciences's long-term debt stands at $13M as of June 2026. That compares with $53M in the prior-year period — down 75.8% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Senti Biosciences reported $13M in long-term debt versus $53M a year earlier — a 75.8% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $53M in the prior-year period — down 75.8% year over year. Sustained growth in long-term debt can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Senti Biosciences's long-term debt evolved across reporting periods, while the comparison chart places SNTI next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.